BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2782
-0.0066 (-2.32%)
At close: Mar 11, 2026, 4:00 PM EDT
0.2529
-0.0253 (-9.09%)
After-hours: Mar 11, 2026, 7:59 PM EDT

BioRestorative Therapies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.60.550.881.7121.033.06
Short-Term Investments
3.8910.1810.1813.04--
Cash & Short-Term Investments
4.4910.7311.0714.7521.033.06
Cash Growth
-65.70%-3.01%-24.97%-29.85%586.11%184071.27%
Accounts Receivable
0.010.190.020.020.010.02
Other Current Assets
0.20.220.310.360.440.11
Total Current Assets
4.7111.1411.3915.1321.473.19
Net Property, Plant & Equipment
0.310.360.510.50.40.5
Other Intangible Assets
0.560.620.710.80.590.66
Other Long-Term Assets
0.070.15----
Total Assets
5.6412.2812.6116.4322.454.35
Accounts Payable
0.860.480.190.170.050.12
Accrued Expenses
0.610.740.710.130.130.77
Current Portion of Long-Term Debt
----0.06-
Current Portion of Leases
--0.160.140.120.16
Other Current Liabilities
1.972.521.545.54--
Total Current Liabilities
3.443.752.615.980.361.04
Long-Term Debt
----0.194.27
Long-Term Leases
---0.160.30.36
Total Long-Term Liabilities
---0.160.494.63
Total Liabilities
3.443.752.616.140.865.68
Preferred Stock
0.010.010.010.020.02-
Common Stock
000000
Additional Paid-in Capital
168.91164.2156.69146.56155.7388.51
Retained Earnings
-166.71-155.68-146.7-136.28-134.15-89.84
Shareholders' Equity
2.218.531010.2921.6-1.33
Total Liabilities & Equity
5.6412.2812.6116.4322.454.35
Total Debt
-00.160.30.674.79
Net Cash (Debt)
4.4910.7310.914.4520.36-1.73
Net Cash Growth
-58.17%-1.57%-24.53%-29.03%--
Net Cash Per Share
0.521.382.583.9917.14-4.38
Book Value
2.218.531010.2921.6-1.33
Book Value Per Share
0.261.102.372.8418.18-3.37
Tangible Book Value
1.657.919.299.4921.01-2
Tangible Book Value Per Share
0.191.022.202.6217.69-5.06
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q